• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    2/9/23 11:12:43 AM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email
    SC 13G/A 1 tv0567-chemedcorp.htm SCHEDULE 13G/A chemedcorp

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 14)*

    Name of issuer:  Chemed Corp.

    Title of Class of Securities:  Common Stock

    CUSIP Number:  16359R103

    Date of Event Which Requires Filing of this Statement: December 30, 2022

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  16359R103

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    6,297

    7.  SOLE DISPOSITIVE POWER

    1,671,536

    8.  SHARED DISPOSITIVE POWER

    20,841

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,692,377

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    11.38%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Chemed Corp.

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    255 East 5th Street, Suite 2600
    Cincinnati, OH 45202-4726

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    16359R103

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 9, 2023

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $CHE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of

      5/14/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS i

      5/6/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      12/30/24 11:10:35 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    SEC Filings

    See more
    • Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CHEMED CORP (0000019584) (Filer)

      5/20/25 2:00:14 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form S-8 filed by Chemed Corp

      S-8 - CHEMED CORP (0000019584) (Filer)

      5/20/25 10:21:08 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Chemed Corp

      10-Q - CHEMED CORP (0000019584) (Filer)

      4/28/25 9:06:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    See more
    • VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

      VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

      3/13/24 9:00:00 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

      Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

      12/18/23 1:20:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Retirement of David P. Williams

      Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed's Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for the transition period and beyond in providing his guidance and the benefit of his expertise to the executive team and the Board of Directors. Throughout his career, David helped lead Chemed and its subsidiaries through unprecedented economic growth. "It has been a privilege to work with David as an integral part of our management team for these last three decades," said Chemed Chief Executive Officer, Kevin

      11/3/23 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Financials

    Live finance-specific insights

    See more
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Reports First-Quarter 2025 Results

      Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in

      4/23/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24

      Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti. Participants may also register via teleconference at: https:/

      4/1/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Walsh George J Iii was granted 277 units of Capital Stock, increasing direct ownership by 9% to 3,323 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:42:26 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mount John Meredith Jr. was granted 277 units of Capital Stock, increasing direct ownership by 42% to 930 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:33:04 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mccarthy Eileen P was granted 277 units of Capital Stock, increasing direct ownership by 48% to 855 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:28:19 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $579.00 from $609.00 previously

      3/4/22 8:31:07 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $609.00 from $604.00 previously

      7/29/21 10:52:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Oppenheimer reiterated coverage on Chemed with a new price target

      Oppenheimer reiterated coverage of Chemed with a rating of Outperform and set a new price target of $580.00 from $600.00 previously

      3/3/21 8:11:56 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/13/24 5:01:01 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/23 11:12:43 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/22 3:33:36 PM ET
      $CHE
      Medical/Nursing Services
      Health Care